Lipoarabinomannan (LAM) can be detected in non-sputum samples, such as urine, plasma, and serum, in the diagnosis of ...

Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) ...

CNP-104 demonstrated potential efficacy across multiple immunological and clinical measurements, supporting its continued development as the first disease-modifying treatment for Primary Biliary ...

South Africa needs to get more than 550 000 HIV-positive men on antiretrovirals before the end of next year to help the ...

The following is a summary of “Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- ...

Anti-CD3 positive cells in epithelial and interstitial ... 17,3% of the sample are stroma (orange outline). 22% of CD8+ T-cells are located in stroma areas (outlined in green).

CD4-cell counts and T-cell activation levels were determined in four groups of patients: 30 HIV-infected elite controllers, 47 HIV-uninfected persons, 187 treated HIV-infected persons with ...

A new study shows that CD8-positive T cells play a significant role in the early stages of multiple sclerosis (MS).

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Human innate immune cells that “remember” previous stimulation could provide new insights into chronic inflammatory diseases.

Poseida Therapeutics' lead allogeneic chimeric antigen receptor T-cell candidate it is co-developing with Roche will advance to Phase Ib.